Craig W. Moore is Director at NxStage Medical, Inc. (NXTM). They have made 6 open-market trades across 1 company since 2008, most recently 2019-02-21.
CIK 0001221380
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $40K since 2008, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NXTM | SELL | 2017-03-16 | 2017-03-16 | $27.93 | $28K | -4.0% | -6.5% | -15.8% |
| NXTM | SELL | 2016-09-12 | 2016-09-14 | $23.31 | $70K | +3.6% | +0.6% | +9.7% |
| NXTM | SELL · 10b5-1 | 2015-11-20 | 2015-11-20 | $20.00 | $20K | -11.6% | -2.1% | -33.4% |
| NXTM | SELL · 10b5-1 | 2015-11-18 | 2015-11-18 | $19.60 | $78K | -11.6% | -2.1% | -34.0% |
| NXTM | SELL | 2015-09-15 | 2015-09-16 | $16.00 | $16K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL | 2011-12-15 | 2011-12-19 | $17.25 | $173K | -11.6% | -2.1% | -2.1% |
| NXTM | SELL | 2010-07-27 | 2010-07-29 | $16.89 | $151K | -11.6% | -2.1% | -2.1% |
| NXTM | BUY | 2008-08-12 | 2008-08-13 | $4.00 | $40K | -11.6% | -2.1% | -2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.